Concepedia

Yves Leestemaker

YL

Statistics

Publications

5

Citations

639

H-Index

5

Active since

2012

Affiliations

Leiden University Medical Center(Current)

The Netherlands Cancer Institute

Oncode Institute

Utrecht University

University of California San Diego

Yves Leestemaker is an author at Leiden University Medical Center specializing in proteasome inhibitors, life sciences, and biochemistry.

Publications per year

2012–2019

5

Publications

5

Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons

Rik van der Kant, Vanessa F. Langness, Cheryl Herrera et al. · Cell stem cell · 2019 · 373 citations · Full text

, , +16

Proteasome Activation by Small Molecules

Yves Leestemaker, Annemieke de Jong, Katharina F. Witting et al. · Cell chemical biology · 2017 · 145 citations · Full text

, , +12

Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification

Christella E. Widjaja, Jocelyn G. Olvera, Patrick J Metz et al. · Journal of Clinical Investigation · 2017 · 55 citations · Full text

, , +14

Probing the Specificity and Activity Profiles of the Proteasome Inhibitors Bortezomib and Delanzomib

Celia R. Berkers, Yves Leestemaker, Karianne Schuurman et al. · Molecular Pharmaceutics · 2012 · 51 citations

, , +13

Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation

Amy L. Palmer, Annemieke de Jong, Yves Leestemaker et al. · The Journal of Immunology · 2017 · 15 citations · Full text

, , +17

1–5 of 5